Related Experiment Video
Updated: Aug 1, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Reduced-rank hazard regression for modelling non-proportional hazards
Aris Perperoglou1, Saskia le Cessie, Hans C van Houwelingen
1Department of Medical Statistics, Leiden University Medical Center, University of Leiden, P.O. Box 9604, 2300 RC, Leiden, The Netherlands. a.perperoglou@lumc.nl
Abstract:
The Cox proportional hazards model is the most common method to analyse survival data. However, the proportional hazards assumption might not hold. The natural extension of the Cox model is to introduce time-varying effects of the covariates. For some covariates such as (surgical)treatment non-proportionality could be expected beforehand. For some other covariates the non-proportionality only becomes apparent if the follow-up is long enough. It is often observed that all covariates show similar decaying effects over time. Such behaviour could be explained by the popular (gamma-) frailty model. However, the (marginal) effects of covariates in frailty models are not easy to interpret. In this paper we propose the reduced-rank model for time-varying effects of covariates. Starting point is a Cox model with p covariates and time-varying effects modelled by q time functions (constant included), leading to a pxq structure matrix that contains the regression coefficients for all covariate by time function interactions. By reducing the rank of this structure matrix a whole range of models is introduced, from the very flexible full-rank model (identical to a Cox model with time-varying effects) to the very rigid rank one model that mimics the structure of a gamma-frailty model, but is easier to interpret. We illustrate these models with an application to ovarian cancer patients.
Related Concept Videos
Ranks
Relative Risk
Comparing the Survival Analysis of Two or More Groups
The Mantel-Cox Log-Rank Test
Hazard Rate
Hazard Ratio
For example, in a clinical trial evaluating a...

